LUCI DAVID P 4
4 · Acurx Pharmaceuticals, Inc. · Filed Jul 29, 2022
Insider Transaction Report
Form 4
LUCI DAVID P
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Warrants for Common Stock
2022-07-27+19,737→ 19,737 totalExercise: $3.55From: 2023-01-27Exp: 2024-01-27→ Common Stock (19,737 underlying) - Purchase
Warrants for Common Stock
2022-07-27+19,737→ 19,737 totalExercise: $3.55From: 2023-01-27Exp: 2028-01-27→ Common Stock (19,737 underlying) - Purchase
Common Stock
2022-07-27$3.80/sh+19,737$75,001→ 1,028,460 total
Holdings
- 35,000(indirect: By Children)
Common Stock
- 15,083(indirect: By Spouse)
Common Stock